Navigation Links
Parkinson’s Drug Linked to Gamblin

A new study finds an unusual side effect from drug therapy in some Parkinson’s patients. Certain dopamine agonists show signs of causing some patients to become excessive gamblers.
Dopamine is a chemical substance that is produced in the brain that allows people to have smooth movements. Parkinson’s patients have a severe shortage of dopamine. Drug therapies for Parkinson’s focus on increasing dopamine. //Researchers at Muhammad Ali Parkinson Research Center in Phoenix conducted a study to see if excessive gambling could be a side effect of one drug therapy.

For the study, researchers looked at the data of 1,884 patients who were seen at the center during one year. They found nine patients had gambling problems. All nine were taking levodopa and a dopamine agonist. In the brain levodopa is transformed into dopamine. The other study drug activates the dopamine receptor in the brain.

None of the patients had a previous history of gambling. Researchers say seven of the patients started gambling within one month after their dosage of the dopamine agonist was increased. All of the patients were in the advanced stages of the disease. Study authors say the gambling was severe enough to cause financial problems and two of the patients lost more than $60,000.

Researchers say after a caretaker or family member noticed the gambling problem, the patients’ drug therapies were changed. For most of the patients the new treatment plan fixed the problem. Researchers feel higher dosages of dopamine agonist may be to blame for excessive gambling. They add while the risk of this side effect is small, doctors need to inform patients about this unusual side effct.
'"/>




Page: 1

Related medicine news :

1. NPIL withdraws Parkinson’s dru
2. Delaying Parkinson’s Diseas
3. New Drug For Parkinson’s Disease With Less Side Effect
4. Embryonic Cells Might Prevent Parkinson’s Disease From Worsenin
5. Magnetic Stimulation For Parkinson’s Diseas
6. Exercising regularly can reduce the risk of Parkinson’s diseas
7. Fetal Cell Transplant Found To Improve Movement In Patients With Parkinson’s Disease
8. New Medicine For Parkinson’s disease
9. A New Addition Could Help Patients With Parkinson’s Disease
10. Milk intake increases the risk of Parkinson’s disease in midlife
11. Ibuprofen to lower risk of Parkinson’s diseas
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Parkinson Drug Linked Gamblin

(Date:1/22/2015)... (PRWEB) January 22, 2015 The federal court ... the U.S. District Court, Southern District of West Virginia has ... in that proceeding’s first bellwether trial. In an Order dated ... new trial after finding that C.R. Bard had not proven ...
(Date:1/22/2015)... Thousand of GranuFlo lawsuits ( http://www.granuflolawsuit2014.com/ ... GranuFlo and NaturaLyte dialysis concentrates continue to move forward ... Court, District of Massachusetts, Bernstein Liebhard LLP reports. According ... remanded a case filed by the state of Louisiana ...
(Date:1/22/2015)... released a new blog post presenting the basic features of ... an accidental death and dismemberment rider for a car insurance ... benefits if the insured dies in an accident. Accidental death ... insurance. , AD&D is not expensive and can be ...
(Date:1/22/2015)... Yesterday, Senator Holly Mitchell (D-Los ... Olsen (R-Modesto) were honored by the California Healthcare ... biomedical science, medical device and pharmaceutical innovation in ... “2014 Life Sciences Champion” award from CHI President ...
(Date:1/22/2015)... years since the release of their debut recording Love is King, ... & Matthew Love – the duo are pleased to announce their ... Swan Records on February 24, 2015. , THE ROAD offers the ... all of us to walk out of the mire of our ...
Breaking Medicine News(10 mins):Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 2Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 3Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 4Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 2Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 3Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 4Health News:Accidental Death and Dismemberment Insurance Can Be Purchased at Low Prices Online 2Health News:California Biomedical Community Honors Senator Holly Mitchell, Assemblymembers Susan Bonilla & Kristin Olsen 2Health News:California Biomedical Community Honors Senator Holly Mitchell, Assemblymembers Susan Bonilla & Kristin Olsen 3Health News:THE ROAD by Avasa & Matthew Love -- A New Album 2Health News:THE ROAD by Avasa & Matthew Love -- A New Album 3Health News:THE ROAD by Avasa & Matthew Love -- A New Album 4
... VIEW, Calif., March 4 Based on ... biotechnology market, Frost & Sullivan presents OVATION ... Frost & Sullivan Award for Entrepreneurial Company ... company,s success in achieving its growth objectives ...
... 4 Cardiogenesis Corporation (Pink Sheets: CGCP), announced that ... and full year ended December 31, 2008 prior to ... company also said that President Richard P. Lanigan and ... Abbott will host an investor conference call that day ...
... NVC-422 Demonstrates Ability to Treat Subcutaneous InfectionsEMERYVILLE, Calif., ... NBY), a clinical stage biopharmaceutical company, today announced ... lead molecule in NovaBay,s, proprietary Aganocide(R) class of ... of Dermatology (AAD) 67th Annual Meeting in San ...
... ,Smart, house for people with dementia are just ... on 4th March, organised by the Engineering and ... is a free event aiming to bring together, ... business people. The event includes a dynamic, interactive ...
... Long Looked For Ways To Whiten Teeth In The Comfort Of Their Own ... As In The Dentist Office. A New Teeth Whitening Product, Hollywood Sexy Smile, ... Same Results Without The Costs and Hassles Of Going To The Dentist Office. ... ...
... drugs and endocrine-disrupting compounds found in our public drinking water are ... report by the Water Research Foundation, the nation,s leading drinking water ... ... 2009 -- The concentrations of pharmaceutical drugs and endocrine-disrupting compounds found ...
Cached Medicine News:Health News:Frost & Sullivan Lauds OVATION Pharmaceuticals for Its Business Model and Ability to Sustain Growth 2Health News:Frost & Sullivan Lauds OVATION Pharmaceuticals for Its Business Model and Ability to Sustain Growth 3Health News:Frost & Sullivan Lauds OVATION Pharmaceuticals for Its Business Model and Ability to Sustain Growth 4Health News:Cardiogenesis Corporation to Report 2008 Fourth Quarter and Year-End Results on March 31st 2Health News:NovaBay Pharmaceuticals Announces New Preclinical Data to be Presented at the American Academy of Dermatology (AAD) 67th Annual Meeting 2Health News:NovaBay Pharmaceuticals Announces New Preclinical Data to be Presented at the American Academy of Dermatology (AAD) 67th Annual Meeting 3Health News:Daisyphone, virtual cocoon and smart house at London science conference 2Health News:Teeth Whitening Ranks Most Desired Cosmetic Procedure For Women. Hollywood Sexy Smile Whitens Teeth At Home 8 Shades Without The Dentist. 2Health News:Levels of Trace Pharmaceuticals in Drinking Water Too Low to Impact Human Health According to Water Research Foundation Study 2Health News:Levels of Trace Pharmaceuticals in Drinking Water Too Low to Impact Human Health According to Water Research Foundation Study 3Health News:Levels of Trace Pharmaceuticals in Drinking Water Too Low to Impact Human Health According to Water Research Foundation Study 4
(Date:1/23/2015)... 2015 Gem Pharmaceuticals announced today that the initial ... the Company,s Phase 2 clinical trial.  This open-label study ... compound, GPX-150 (an investigational medication), in approximately 30 adults ... Logo - http://photos.prnewswire.com/prnh/20150123/170966LOGO ...
(Date:1/22/2015)... a privately held medical device company, announced today that ... ITOCHU Corporation (Tokyo Stock Exchange TYO: 8001) to sell ... cancer in Japan . ViewRay,s technology, ... only MRI-guided radiation therapy system that images and treats ...
(Date:1/22/2015)... Jan. 22, 2015  ResMed Inc. (NYSE: RMD ) ... Revenue for the quarter was $423.0 million, a 10 percent ... 14 percent increase on a constant currency basis). Net income ... the quarter ended December 31, 2013. Diluted earnings per share ...
Breaking Medicine Technology:Gem Pharmaceuticals Announces Enrollment of Initial Patients in its Phase 2 Clinical Trial to Assess the Efficacy and Safety of GPX-150 in Sarcoma Patients 2ITOCHU Named the Exclusive Distributor for ViewRay's MRI-Guided Radiation Therapy System in Japan 2ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 2ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 3ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 4ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 5ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 6ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 7ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 8ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 9ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 10ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 11
... London, UK, June 11, 2007-ReGen is pleased to ... on Colostrinin, its,nutraceutical product which the Company believes ... presented today at the,2007 International Congress on Natural ... Kruzel, ReGen's Chief,Scientific Officer. , The conference, which ...
... Norway, 11 June 2007 - Clavis Pharma (OSE: ... clinical Phase I/II,study with ELACYT in hematologic cancers ... the European Hematology Association (EHA) in,Vienna. ELACYT is ... of hematologic cancers as well as for solid ...
Cached Medicine Technology:Data Showing that ReGen's Colostrinin Supports Healthy Cognitive,Function Presented at the 2007 International Congress on Natural,Medicine in Australia 2Clavis Pharma Presented Preliminary Clinical Data on Elacyt at EHA 2
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: